Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Data shows Cambridge biotech’s muscular dystrophy treatment is effective

10/07/2014 by

W1siziisijiwmtqvmtavmjgvmtuvmzmvndyvmzq0l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

A Cambridge biotechnology company developing a treatment for a severe form of muscular dystrophy that progresses rapidly presented three years of data Thursday that show the drug is helping to slow the effects of the fatal, muscle-wasting disease.

With the positive results, Sarepta Therapeutics will seek approval from the Food and Drug Administration later this year with the goal of selling the drug, called eteplirsen, in 2015, to treat the disease known as Duchenne muscular dystrophy. If approved, it would be Sarepta’s first commercial drug.

“We’re very encouraged by this data,” Sarepta’s chief executive, Chris Garabedian, said in an interview. “This is more evidence that the FDA can look at to positively review eteplirsen’s treatment benefits.”

Duchenne muscular dystrophy occurs in about 1 of every 3,500 boys, destroying muscle function and quality of life over time. The disease moves swiftly, robbing most boys of the ability to walk by their teen years, and damaging their respiratory muscles. Duchenne patients typically do not live past their 20s.

This article has been extracted from http://www.bostonglobe.com, please click on this link to read the article in full http://www.bostonglobe.com/business/2014/07/10/data-shows-cambridge-biotech-muscular-dystrophy-treatment-effective/8qULRRssaguT8qFw26tqXP/story.html

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtyvmtivmdivmtavmdcvntcvotkwl2j1c2luzxnzigludgvsbglnzw5jzs5qcgcixsxbinailcj0ahvtyiisijm4mhgxmdajil1d

Annual growth rate for BI market set at 8.4%

2016-12-02 10:00:00 +0000

A new report has suggested that the compound average growth rate (CAGR) for the business intelligence (BI) market between 2016 and 2021 is likely to be around 8.4 per cent. The latest publication, named Global Business Intelligence Market by Mobile BI, Cloud BI, and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015-2021, said that 2015 saw the global BI sector valued at $16.33 billion. By 2021, this is expected t...

W1siziisijiwmtyvmtevmzavmtavmjavntuvndgzl09jbcbyawcgc2vhlmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Crisis in oil and gas industry nears turning ...

2016-11-30 10:00:00 +0000

A new report has suggested that the current crisis being experienced by the gas and oil industry is nearing a turning point. As part of the 25th Oil and Gas Survey, it was found that although two-thirds of firms had cut employment levels in 2015, the speed at which these cuts are occurring has slowed. In addition, other methods of saving have been utilised to drive operational costs down. Amongst the firms questioned, it was found that 67 per cent of bu...